Gene · 2938
Papers2,060
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,060
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Multifaceted Role of Glutathione S-Transferases in Health and Disease. | Biomolecules | 2023 | 37189435 | PubTator, text mining | PubMed |
| Hypericin as a potential drug for treating Alzheimer's disease and type 2 diabetes with a view to drug repositioning. | CNS Neurosci Ther | 2023 | 37183545 | PubTator, text mining | PubMed |
| Potential therapeutic benefit of ursodeoxycholic acid in the management of non hepato-biliary upper gastrointestinal disorders. | Saudi Med J | 2023 | 37182914 | PubTator, text mining | PubMed |
| Injury activated alveolar progenitors (IAAPs): the underdog of lung repair. | Cell Mol Life Sci | 2023 | 37166489 | PubTator, text mining | PubMed |
| Proteome changes in a human retinal pigment epithelial cell line during oxidative stress and following antioxidant treatment. | Front Immunol | 2023 | 37153596 | PubTator, text mining | PubMed |
| Clinical outcomes of chemotherapy in cancer patients with different ethnicities. | Cancer Rep (Hoboken) | 2023 | 37150853 | PubTator, text mining | PubMed |
| A human model of asthma exacerbation reveals transcriptional programs and cell circuits specific to allergic asthma. | Sci Immunol | 2023 | 37146132 | PubTator, text mining | PubMed |
| Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial. | Clin Cancer Res | 2023 | 37134194 | PubTator, text mining | PubMed |
| A Focus on the Synergy of Radiomics and RNA Sequencing in Breast Cancer. | Int J Mol Sci | 2023 | 37108377 | PubTator, text mining | PubMed |
| Long-Term Transcriptomic Changes and Cardiomyocyte Hyperpolyploidy after Lactose Intolerance in Neonatal Rats. | Int J Mol Sci | 2023 | 37108224 | PubTator, text mining | PubMed |
| Identification of Hub Genes and Immune Infiltration in Non-alcoholic Fatty Liver Disease -Related Hepatocellular Carcinoma by Bioinformatics Analysis. | Turk J Gastroenterol | 2023 | 37089050 | PubTator, text mining | PubMed |
| Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan. | Bone Marrow Transplant | 2023 | 37085674 | PubTator, text mining | PubMed |
| Long-term organoid culture of a small intestinal neuroendocrine tumor. | Front Endocrinol (Lausanne) | 2023 | 37082125 | PubTator, text mining | PubMed |
| New High-Throughput Screen Discovers Novel Ligands of Full-Length Nuclear Receptor LRH-1. | ACS Chem Biol | 2023 | 37074920 | PubTator, text mining | PubMed |
| Regulatory mechanism and research progress of ferroptosis in obstetrical and gynecological diseases. | Front Cell Dev Biol | 2023 | 37065851 | PubTator, text mining | PubMed |
| A novel pyroptosis-related model for prognostic prediction in esophageal squamous cell carcinoma: a bioinformatics analysis. | J Thorac Dis | 2023 | 37065557 | PubTator, text mining | PubMed |
| Ethacrynic Acid: A Promising Candidate for Drug Repurposing as an Anticancer Agent. | Int J Mol Sci | 2023 | 37047688 | PubTator, text mining | PubMed |
| Molecular and Functional Characteristics of Airway Epithelium under Chronic Hypoxia. | Int J Mol Sci | 2023 | 37047450 | PubTator, text mining | PubMed |
| Heterogeneous pattern of gene expression driven by TTN mutation is involved in the construction of a prognosis model of lung squamous cell carcinoma. | Front Oncol | 2023 | 37035196 | PubTator, text mining | PubMed |
| A novel integrative multi-omics approach to unravel the genetic determinants of rare diseases with application in sinusoidal obstruction syndrome. | PLoS One | 2023 | 37018234 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2938/papers?page=9